Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.60 -0.07 (-2.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) EV to EBIT (2024)

Updated

Kiora Pharmaceuticals' EV to EBIT was -3.11 in Q4 2024.

Analysis

Kiora Pharmaceuticals (KPRX) EV to EBIT (2024) Analysis & Trends

From Q1 2024 onward, Kiora Pharmaceuticals has reported EV to EBIT for 4 quarters.

  • Quarterly EV to EBIT has moved between -5.00 (Q1 2024) and -2.75 (Q3 2024) over five years.
  • Per Business Quant data, KPRX's EV to EBIT in the three quarters before Q4 2024 was -2.75 (Q3 2024), -3.90 (Q2 2024) and -5.00 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Kiora Pharmaceuticals 16.49 Mn 16.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.11
Sep 30, 2024 -2.75
Jun 30, 2024 -3.90
Mar 31, 2024 -5.00
API Access

Kiora Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=KPRX&period=max&api_key=YOUR_API_KEY